Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7094686
Reference Type
Journal Article
Title
Marine natural products: A lead for Anti-cancer
Author(s)
Md, SH; Fareed, S; Ansari, S; Khan, MS; ,
Year
2012
Is Peer Reviewed?
1
Journal
Indian Journal of Marine Sciences
ISSN:
0379-5136
Publisher
NATL INST SCIENCE COMMUNICATION-NISCAIR
Location
NEW DELHI
Page Numbers
27-39
Web of Science Id
WOS:000301614300004
Abstract
Various active anticancer agents are derived from plants and terrestrial microorganisms. Isolation of C-nucleosides from the Caribbean sponge, Cryptotheca crypta, four decades ago, provided the basis for the synthesis of cytarabine, the first marine derived anticancer agent to be developed for clinical use. Cytarabine is currently used in the routine treatment of patients with leukaemia and lymphoma. Gemcitabine, one of its fluorinated derivatives, has also been approved for use in patients with pancreatic, breast, bladder, and non-small-cell lung cancer. Over the past decade, several new experimental anticancer agents derived from marine sources have entered preclinical and clinical trials. Present study address anticancer drug discovery from an evolutionary perspective and present a series of case studies that demonstrate that the rate of anticancer drug discovery can be increased greatly by targeted screening of natural compounds from marine sources.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity